Navigation Links
MedLook 3.0

ProductsMedLook 3.0
Company Fagerman Technologies, Inc.
Item MedLook 3.0
Features 
  • Navigation via folder list, button bar, menus and shortcuts
  • Context sensitive HTML help
  • Flash tutorials in help file and on-line
  • Grids customized for grouping, sorting, colors, fields shown, fonts, etc.
  • Accelerators via menus, navigation bars, key sequences
  • Line item selectable
  • Save batches for reprint
  • Customizable
  • Print by date range
  • Process paper and print to file claims at the same time
  • Supports print image of the HCFA 1500 form
  • Batch and individual claims
  • Claims tested with a number of clearinghouses
  • Claims with Ivertex Solace
  • View charges and associated payments
  • View payments and associated charges
  • Patient recalls
  • Insurance reimbursement
  • CPT code usage
  • Flexible notes for each patient
  • Stored in rich text format (rtf)
  • Use built in editor or preferred word processor
  • Search functionality
  • Format fonts, colors, etc.
  • Include graphics, audio, video, etc.
  • Multiple appointments simultaneously
  • Next appointment prints with bill
  • Multi-day, week, month views
  • Multi-resource views
  • Colors, times, etc., user configurable (per user)
  • Reports by day, week, past, present, future, patient, status, etc.
Description MedLook 3.0 is a medical billing software.
Info Fagerman Technologies, Inc.
Customer Service: 800-548-6148
Web site: http://www.remsys.com/index.shtml

Related medicine products :

1. PrimeSuite Integrated Practice Management, Electronic Medical Record (EMR) and Managed Care solutions
TAG: MedLook
The Shandon Linistat Linear Stainer is a compact answer to H&E frozen section protocols, with a footprint that fits on top of most cryostas to streamline workflow during frozen sectioning.
The Shandon Finesse 315 low-cost precision microtome is ergonomically designed to consistently produce high quality routine paraffin sections without user strain or fatigue.
The Shandon Cryotome E Cryostat model features an automated, precise electronic specimen advance system.
The Shandon Pathcentre is a high-volume, totally enclosed tissue processor that allows complete user control and excellent continuous reagent agitation.
Medicine Products:
(Date:8/8/2008)...gnosis, less successful surgery, pair of studies f... -- The standard screening test for prostate cance...more vulnerable to the disease, and surgery is les...tudies found. , "Obese men are more likely to b...," said Dr. Stephen Freedland, an associate profes...
(Date:8/8/2008)...A, Md., Aug. 8 /PRNewswire-FirstCall/ -- Hanger Or...nnounce that Moody,s Investors,Service revised its...itive",from "stable." Moody,s also affirmed Hanger...re pleased with the outlook change from Moody,s as...ten quarters," remarked George McHenry,Hanger,s C...
(Date:8/7/2008)...ls of testosterone may be a key factor in spreadin... findings could help explain why males in a popula...ansmit disease., , Previous research has linked...tem suppression. Studies have shown that males, co...e, and account for a larger share of disease trans...
(Date:8/7/2008)...urgh Tissue Engineering Initiative Marks 12th Year...p, PITTSBURGH, Aug. 7 /PRNewswire/ -- Twenty-four...ties, primarily across southwestern Pennsylvania,a...2th annual Summer,Internship Program of the Pittsb...l of the program is to expose greatly increased nu...
Breaking Medicine News(10 mins):Health News:Obese Men Face Twin Threat From Prostate Cancer 2Health News:Testosterone key to disease transmission 2Health News:Thirty-seven College Students Participate in Regenerative Medicine Summer Research Program 2Health News:Thirty-seven College Students Participate in Regenerative Medicine Summer Research Program 3
...nticipation of a fearful situation can play an imp... the University of Wisconsin-Madison, while conduc...f memory have come up with the findings that the v...l situation can stir up two memory-forming regions...
...atients taking newer blood pressure drugs have a d... an analysis of the biggest clinical trial in Euro...eople on newer medicines developed diabetes as aga...ugs. The study involved 19,000 people. The study ...
... study in the September issue of Archives of Pedia...ves journals says that hospitals must be prepared ...f and equipment to treat injured and noninjured ch...he report is based on the experience of training a...
...olgate-Palmolive (India) Limited, the market leade...tal Association (IDA) today announced that Septemb... in its third year, Oral Health Month (OHM) is an ...gn in India to establish and promote the importanc...
Other Medicine News:Health News:Anticipation Could Have An Intense Effect On Memory 2Health News:Anticipation Could Have An Intense Effect On Memory 3Health News:Military Hospitals Need To Be Prepared To Treat Children 2Health News:Striving to Make India Free from Tooth Decay 2
(Date:8/7/2008)...ve Decision to Expand its Proprietary ...rland, Aug. 7 /- ESBATech AG, a leadi...day announced that the,company has raised an addit...ries B venture round to expand its development pip...ticipated in this round including SV Life,Sciences...
(Date:8/6/2008)...manently implanted into the heart works,with an el...s patient,s,pulmonary artery pressure, CHICAGO, A...ortness of,breath are common symptoms that send te...o U.S. hospitals each month. Cardiologists at the ...orial Hospital may be able to,curb such visits for...
(Date:8/6/2008)...re-FirstCall/ -- GlaxoSmithKline (NYSE:,GSK) (GSK)...4,600 patients,in 54 clinical studies showed no in...ith the anti-HIV medication abacavir. GSK conducte...rtaken by the D:A:D cohort had found an,unexpected...ntiretroviral,therapy (HAART) regimens containing ...
(Date:8/6/2008)...s $15 million payment from collaborator ...., Aug. 6 /- Tolerx, Inc., a,biopharm...elopment of novel,therapies for immune-mediated di...l Phase 3 clinical trial that is evaluating otelix... a result of the initiation of,patient dosing in D...
Breaking Medicine Technology:ESBATech Raises Additional CHF 23M (USD 22M), Extending Series B Venture Financing 2ESBATech Raises Additional CHF 23M (USD 22M), Extending Series B Venture Financing 3New Implant Device Remotely Monitors Heart Failure Patients at Northwestern Memorial's Bluhm Cardiovascular Institute 2New Implant Device Remotely Monitors Heart Failure Patients at Northwestern Memorial's Bluhm Cardiovascular Institute 3Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy 2Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy 3Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy 4Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy 5Tolerx Initiates Dosing of Otelixizumab, a Novel Type 1 Diabetes Agent, in DEFEND, a Phase 3 Clinical Trial 2Tolerx Initiates Dosing of Otelixizumab, a Novel Type 1 Diabetes Agent, in DEFEND, a Phase 3 Clinical Trial 3Tolerx Initiates Dosing of Otelixizumab, a Novel Type 1 Diabetes Agent, in DEFEND, a Phase 3 Clinical Trial 4Cipher appoints Stefan Aigner to board of directors 7671 1Cipher appoints Stefan Aigner to board of directors 7671 2Cipher appoints Stefan Aigner to board of directors 7671 3Wyeth Receives Honors at the 2007 Scrip Awards 7667 1Wyeth Receives Honors at the 2007 Scrip Awards 7667 2Wyeth Receives Honors at the 2007 Scrip Awards 7667 3Wyeth Receives Honors at the 2007 Scrip Awards 7667 4Wyeth Receives Honors at the 2007 Scrip Awards 7667 5Dads break bones of children more often than moms 7663 1Dads break bones of children more often than moms 7663 2Scientists identify gene that influences alcohol consumption 7659 1Scientists identify gene that influences alcohol consumption 7659 2
...al protection,against infection with other cancer-...PRNewswire-FirstCall/ -- The,GlaxoSmithKline cervi...rated 100 percent efficacy in preventing precancer...irus types 16 and 18,for up to 5.5 years in an ext... today at the American Association for Cancer,Rese...
...st-Ever IVF Trial,in US, RANCHO MIRAGE, Calif., Ap...es evaluating Ferring Pharmaceuticals, ENDOMETRIN(...ment for luteal phase,support (supplementation to ...ges of pregnancy) in assisted reproductive,technol...ing of the,Pacific Coast Reproductive Society in R...
Other Medicine Technology:Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 2Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 3Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 4Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 5Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 2Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 3Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 4Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 5